[Pfizer cuts its annual revenue forecast, implying layoffs] According to a Reuters report on the 14th local time, the US biopharmaceutical company Pfizer cut its annual revenue forecast by about 13% on the 13th, because its sales of COVID-19 vaccines and therapeutic drugs were lower than expected. At present, it is expected that the company's revenue will be between $58 billion and $61 billion in 2023, lower than the previous forecast of $67 billion to $70 billion. In addition, the company also stated that it will cut costs, with a goal of saving at least $3.5 billion by the end of 2024. The measures include layoffs, but Pfizer did not provide details on the number of layoffs or areas of layoffs.